Chronic skin wounds represent an escalating clinical dilemma globally, particularly in patients suffering from diabetic foot ulcers, pressure injuries, and peripheral vascular insufficiency. Consequently, healing frequently stalls because the physiological microenvironment shifts toward alkaline pH, persistent infection, and sustained inflammatory cascades. Standard therapeutic dressings often fail to address these dynamic bio-pathological fluctuations or provide anatomical personalization for irregularly contoured lesions. To resolve this therapeutic bottleneck, bioengineers have developed an innovative pH-responsive wound dressing designed for 3D bioprinting applications. By leveraging a tailor-made poly(ether urethane) hydrogel loaded with human recombinant lactoferrin, this cutting-edge platform dynamically responds to wound alkalinity, suppresses destructive cytokines, and accelerates tissue restoration.

Overcoming Pathophysiological Hurdles in Chronic Non-Healing Wounds

Under normal physiological conditions, cutaneous tissue maintains an acidic barrier that discourages microbial colonization and coordinates cell differentiation. In stark contrast, non-healing ulcers exhibit elevated alkaline exudate levels ranging from pH 7.2 to 8.9. This chronic alkalinity stems from bacterial colonization, enzymatic urea degradation, and sustained necrotic debris accumulation. Furthermore, pathogenic bacteria such as Staphylococcus aureus exploit this alkaline shift to establish resilient biofilms and resist traditional topical antimicrobials. Simultaneously, persistent immune activation stimulates inflammatory macrophages to release excessive quantities of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and interleukin-6 (IL-6). These mediators induce premature matrix metalloproteinase synthesis, which rapidly destroys extracellular matrix components and prevents fibroblast migration. Therefore, effective therapeutic interventions require intelligent biomaterials that perceive microenvironmental fluctuations and deliver restorative agents on demand.

Engineering a Custom pH-Responsive Wound Dressing Platform

To construct this responsive system, researchers synthesized a specialized carboxyl-bearing (-COOH) amphiphilic poly(ether urethane) framework. This molecular architecture provides exceptional dual-stimuli functionality, allowing the hydrogel to modulate its physical network in response to both physiological temperature and alkaline pH. At physiological temperatures, hydrophobic associations drive rapid physical gelation, ensuring mechanical stability across diverse tissue topographies. Moreover, when the material encounters the alkaline exudate characteristic of infected chronic wounds, the pendant carboxyl moieties undergo progressive deprotonation. This electrostatic repulsion induces swelling within the polymeric matrix, triggering controlled cargo release. Rheological assessments verified that the formulation possesses shear-thinning behavior, which enables smooth extrusion during manufacturing. Consequently, investigators can utilize this formulation as a sophisticated biomaterial ink for 3D bioprinting, establishing customized, patient-specific patches tailored to complex wound beds.

Therapeutic Actions of Human Recombinant Lactoferrin

Rather than relying solely on conventional antibiotics that promote drug resistance, the research team encapsulated human recombinant lactoferrin (hrLF) into the poly(urethane) matrix. Lactoferrin functions as an essential, naturally derived multifunctional glycoprotein with extensive physiological immunomodulatory and regenerative properties. However, chronic wound fluid contains hostile proteolytic enzymes that frequently degrade bioactive peptides before they exert clinical effects. Therefore, the researchers evaluated hrLF stability within hostile biological environments using ultraviolet-visible spectroscopy and specialized colorimetric degradation assays. The data demonstrated that the protective poly(ether urethane) hydrogel shields the encapsulated protein from aggressive enzymatic proteolysis. Subsequently, drug-release kinetics revealed a non-Fickian, anomalous diffusion mechanism strictly dictated by surrounding pH shifts. Thus, the system accelerates hrLF liberation exclusively when encountering alkaline infection markers, ensuring localized therapeutic action while sparing healthy surrounding tissues.

Suppressing Inflammation and Restoring Fibroblastic Proliferation

Chronic tissue wounds remain suspended within an unresolving inflammatory phase, preventing transition into proliferative remodeling. In vitro assays evaluating simplified inflamed wound environments revealed that hrLF-loaded hydrogels remarkably mitigate this pathology. Specifically, the formulations significantly suppressed the transcription and secretion of pivotal inflammatory cytokines, including TNF-α, IL-1β, and IL-6. By dampening this destructive biochemical feedback loop, the hydrogel prevents excessive leukocyte recruitment and limits collateral tissue proteolysis. Simultaneously, the sustained delivery of bioactive lactoferrin stimulated human dermal fibroblast proliferation, confirmed by marked increases in cellular DNA content. Furthermore, fibroblasts exhibited enhanced metabolic viability and migratory capability across wound margins. Because fibroblasts synthesize structural collagen and glycosaminoglycans, this targeted cellular stimulation re-establishes the foundational dermal architecture necessary for lasting clinical re-epithelialization.

Antimicrobial Efficacy Against Resistant Staphylococcus aureus

Bacterial contamination represents a primary obstacle preventing clinical granulation tissue formation in diabetic ulcers. In this study, the hrLF-loaded hydrogel exhibited pronounced bacteriostatic activity against Staphylococcus aureus, one of the most prevalent clinical isolates in chronic wounds. Rather than causing non-specific cytotoxicity, lactoferrin disrupts bacterial membrane integrity and chelates essential iron ions vital for microbial survival. Furthermore, the rate-dependent, pH-triggered release profile ensured that higher bacterial loads, which exacerbate wound alkalinity, induced rapid compensatory therapeutic deployment. This feedback-driven mechanism effectively suppressed microbial expansion without encouraging antimicrobial resistance. Additionally, cell culture experiments confirmed that the formulation maintained high cytocompatibility toward native mammalian cells, displaying negligible cytotoxicity. Consequently, the hydrogel accomplishes simultaneous microbicidal suppression and cellular preservation, establishing a favorable niche for unhindered re-epithelialization.

Clinical Implications and Translational Potential for Wound Care

From a translational perspective, this responsive biomaterial represents a major paradigm shift toward precision wound medicine. In clinical practice, particularly across India where diabetic foot ulcers present massive clinical and financial burdens, conventional generic gauze dressings remain largely suboptimal. They fail to conform to deep, undermined ulcer contours and do not react to changing microbial kinetics. In contrast, integrating this amphiphilic poly(urethane) hydrogel with 3D bioprinting allows clinicians to fabricate custom-fitted patches matching exact patient wound geometries. Moreover, the self-regulating therapeutic release mitigates frequent painful dressing changes, lowering secondary trauma and hospital visits. While these preclinical findings demonstrate remarkable efficacy, future clinical trials must establish long-term safety, cost-effectiveness, and scalability across diverse clinical settings. Ultimately, smart responsive formulations provide a promising pathway toward reducing chronic ulcer recurrence and amputation rates worldwide.

How does a pH-responsive wound dressing differentiate between healthy skin and infected tissue?

Healthy human skin preserves a mildly acidic surface pH between 4.5 and 5.5, which restricts opportunistic pathogen proliferation. In contrast, chronic and infected wounds develop an alkaline microenvironment ranging from pH 7.2 to 8.9 due to bacterial waste products and persistent tissue breakdown. The responsive carboxyl groups in the hydrogel undergo deprotonation specifically at alkaline pH. Consequently, the matrix swells and discharges its active therapeutic payload selectively upon encountering infected tissue exudates.

Why is human recombinant lactoferrin preferred over standard topical antibiotics in chronic wounds?

Topical antibiotics carry a substantial risk of inducing secondary contact dermatitis and fueling widespread antimicrobial resistance. Conversely, human recombinant lactoferrin serves as a physiological glycoprotein with dual anti-inflammatory and bacteriostatic functions. Lactoferrin limits microbial proliferation by sequestering essential free iron and disrupting bacterial membranes, notably against Staphylococcus aureus. Additionally, it actively suppresses destructive cytokines like TNF-α and IL-6 while simultaneously stimulating dermal fibroblast proliferation, promoting genuine tissue regeneration without promoting microbial drug resistance.

What advantage does 3D bioprinting provide for managing complex chronic skin wounds?

Standard planar wound dressings cannot accurately conform to irregular depths, undermined margins, or asymmetrical geometries found in severe diabetic or pressure ulcers. By formulating this poly(urethane) hydrogel as an adaptable biomaterial ink, clinicians can leverage optical scanning and 3D bioprinting to construct custom-tailored anatomical patches. This personalized morphology maximizes direct surface contact with infected wound beds, enhances exudate absorption, and ensures localized, homogeneous distribution of therapeutics precisely where tissue necrosis and inflammation persist.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Laurano R et al. Customized pH-responsive poly(urethane)-based formulations treating chronic skin wound inflammation and promoting tissue regeneration. Biomater Sci. 2026 Sep 08. doi: 10.1039/d6bm00877a. PMID: 42707025.
2. Ghaznaveh N, et al. Synthesis and Evaluation of Functionalized Polyurethanes for pH-Responsive Delivery of Compounds in Chronic Wounds. Gels. 2023;9(8):611.
3. Liang Y, et al. pH/Glucose Dual Responsive Metformin Release Hydrogel Dressings with Adhesion and Self-Healing via Dual-Dynamic Bonding for Athletic Diabetic Foot Wound Healing. ACS Nano. 2022;16(2):3194-3207.